Avadel climbs as Lundbeck outbids Alkermes in latest bidding war
Source: SeekingAlpha
2025-11-14 06:57:52 ET
Avadel Pharmaceuticals ( AVDL ) announced on Friday that Danish drugmaker Lundbeck ( OTCPK:HLBBF ) submitted an unsolicited proposal to acquire the company for up to $23 per share, compared to up to $20.00 per share offered by Irish biotech Alkermes ( ALKS ) in an earlier takeover bid....
Read the full article on Seeking Alpha
For further details see:
Avadel climbs as Lundbeck outbids Alkermes in latest bidding war
H. Lundbeck
NASDAQ: HLBBF
HLBBF Trading
0.0% G/L:
$6.2075 Last:
100 Volume:
$6.2075 Open:
